CERK and Alzheimer disease: Human AD brain samples display high mRNA levels of CERS1 and CERS2 (ceramide synthases), SPTLC2 (serine palmitoyltransferase), or SGPL1 (S1P lyase), and low expression of CERK (ceramide kinase) or ASAH1 (acid ceramidase) [8].